Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib

References

• American Cancer Society. Global cancer facts & figures. 2nd ed. Atlanta: American Cancer Society, 2011.
   Google Scholar
• Bragagni M, Maestrelli F, Mennini N, Ghelardini C, Mura P. Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy. J Liposome Res 2010;20:315–322.
   PubMed Web of Science ®Google Scholar
• Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996;13:257–388.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 2001;1514:191–205.
   PubMed Web of Science ®Google Scholar
• Chawla G, Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. Characterization of solid-state forms of celecoxib. Eur J Pharm Sci 2003;20:305–317.
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000;21:1879–1885.
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007;67:398–405.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203–222.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 2006;322:60–66.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 2007;62:133–137.
   PubMed Web of Science ®Google Scholar
• Fang JY, Hwang TL, Huang YL, Fang CL. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006;310:131–138.
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 2003;20:63–102.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Liposome technology. II ed. Boca Raton, FL: CRC Press, 2000:367–398.
   Google Scholar
• Hatton JL, Parent AE, Hoppes T, Kusewitt DF, Vanbuskirk AM, Oberyszyn TM. Topical celecoxib decreases the exacerbated UVB-induced skin inflammation and carcinogenesis seen in immunosuppressed mice. Proc Amer Assoc Cancer Res 2005;46.
   Google Scholar
• Jain SK, Gupta Y, Jain A, Bhola M. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery. Drug Deliv 2007;14:327–335.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 2008;346:124–132.
   PubMed Web of Science ®Google Scholar
• Lee JL, Mukhtar H, Bickers DR, Kopelovich L, Athar M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol Appl Pharmacol 2003;192:294–306.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Mönkkönen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release 1999;58:207–214.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, Ghelardini C, Mura P. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm 2010;395:222–231.
   PubMed Web of Science ®Google Scholar
• Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 2001;76:1253–1265.
   PubMed Web of Science ®Google Scholar
• McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg 2004;23:174–183.
   PubMed Web of Science ®Google Scholar
• Mennini N, Furlanetto S, Cirri M, Mura P. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-ß-cyclodextrin-PVP complex. Eur J Pharm Biopharm 2012;80:67–75.
   PubMed Web of Science ®Google Scholar
• Micali G, Lacarrubba F, Dinotta F, Massimino D, Nasca MR. Treating skin cancer with topical cream. Expert Opin Pharmacother 2010;11:1515–1527.
   PubMed Web of Science ®Google Scholar
• Minghetti P, Cilurzo F, Casiraghi A, Montanari L. Evaluation of ex vivo human skin permeation of genistein and daidzein. Drug Deliv 2006;13:411–415.
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 2004;285:23–34.
   PubMed Web of Science ®Google Scholar
• Mura P, Maestrelli F, González-Rodríguez ML, Michelacci I, Ghelardini C, Rabasco AM. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 2007;67:86–95.
   PubMed Web of Science ®Google Scholar
• Mura P, Capasso G, Maestrelli F, Furlanetto S. Optimization of formulation variables of benzocaine liposomes using experimental design. J Liposome Res 2008;18:113–125.
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005;106:99–110.
   PubMed Web of Science ®Google Scholar
• Rattanapak T, Young K, Rades T, Hook S. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J Pharm Pharmacol 2012. DOI: 10.1111/j.2042-7158.2012.01535.x
   PubMed Web of Science ®Google Scholar
• Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283–287.
   PubMed Web of Science ®Google Scholar
• Sohrabi M, Soleimani J, Roshangar L, Vatansever S, Arbabi F, Khaki AA, Abbasi MM, Dustar Y, Javadzadeh Y. The effect of dietary and topical celecoxib on 4-nitroquinoline-1-oxide-induced lingual epithelium alterations in rat. J Pak Med Assoc 2009;59:769–774.
   PubMedGoogle Scholar
• Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010;146:279–282.
   PubMed Web of Science ®Google Scholar
• Subramanian N, Ghosal SK, Moulik SP. Topical delivery of celecoxib using microemulsion. Acta Pol Pharm 2004;61:335–341.
   PubMedGoogle Scholar
• Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403–418.
   PubMed Web of Science ®Google Scholar
• Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 2006;19:106–121.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004;270:119–125.
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003;55:271–277.
   PubMed Web of Science ®Google Scholar
• Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. Mol Carcinog 2003;38:33–39.
   PubMed Web of Science ®Google Scholar
• Wilgus TA, Breza TS Jr, Tober KL, Oberyszyn TM. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors. J Invest Dermatol 2004;122:1488–1494.
   PubMed Web of Science ®Google Scholar
• Yener G, Gönüllü U, Uner M, Degim T, Araman A. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin. Pharmazie 2003;58:330–333.
   PubMed Web of Science ®Google Scholar